(Q33514114)

27 July 2017

High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression (English)

1 reference

27 July 2017

1 reference

Lars Dyrskjøt

8

0 references

author name string

Frederikke Lihme Egerod

1

1 reference

27 July 2017

Annette Bartels

2

1 reference

27 July 2017

Niels Fristrup

3

1 reference

27 July 2017

Michael Borre

4

1 reference

27 July 2017

Torben F Ørntoft

5

1 reference

27 July 2017

Martin B Oleksiewicz

6

1 reference

27 July 2017

Nils Brünner

7

1 reference

27 July 2017

language of work or name

English

0 references

publication date

30 October 2009

1 reference

27 July 2017

1 reference

27 July 2017

9

1 reference

27 July 2017

385

1 reference

Creative Commons Attribution 2.0 Generic

27 July 2017

start time

30 October 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

exact match

https://scigraph.springernature.com/pub.10.1186/1471-2407-9-385

0 references

cites work

HYAL-1 hyaluronidase: a potential prognostic indicator for progression to muscle invasion and recurrence in bladder cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774864

Molecular markers for detection, surveillance and prognostication of bladder cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774864

Epigenetic regulation of HYAL-1 hyaluronidase expression. identification of HYAL-1 promoter

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774864

Biological markers in the diagnosis of recurrent bladder cancer: an overview

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774864

Potential of urinary biomarkers in early bladder cancer diagnosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774864

hEGR1 is induced by EGF, inhibited by gefitinib in bladder cell lines and related to EGF receptor levels in bladder tumours

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774864

HYAL1 hyaluronidase in prostate cancer: a tumor promoter and suppressor

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774864

REporting recommendations for tumour MARKer prognostic studies (REMARK)

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774864

Higher than expected association of clinical prostate and bladder cancers

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774864

HYAL1 hyaluronidase: a molecular determinant of bladder tumor growth and invasion

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774864

Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774864

Inhibition of Egr-1 expression reverses transformation of prostate cancer cells in vitro and in vivo

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774864

Egr1 promotes growth and survival of prostate cancer cells. Identification of novel Egr1 target genes

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774864

Heparanase expression in primary and metastatic pancreatic cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774864

Impaired prostate tumorigenesis in Egr1-deficient mice

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774864

Estimates of the worldwide mortality from 25 cancers in 1990.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774864

Tissue microarrays for high-throughput molecular profiling of tumor specimens

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774864

Expression of early growth response genes in human prostate cancer.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774864

Promoter CpG hypomethylation and transcription factor EGR1 hyperactivate heparanase expression in bladder cancer

28 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-385

Biomarkers for early effects of carcinogenic dual-acting PPAR agonists in rat urinary bladder urothelium in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-385

Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-385

Egr1 transcription factor: multiple roles in prostate tumor cell growth and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-385

The nuclear, 75 kDa form of early growth response protein-1/nerve growth factor-induced A protein is primarily restricted to LH beta-subunit-expressing cells in rat anterior pituitary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-385

Hyalurondiase: both a tumor promoter and suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-385

PPARalpha and PPARgamma are co-expressed, functional and show positive interactions in the rat urinary bladder urothelium

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774864

Differential proteomic analysis of nuclear matrix in muscle-invasive bladder cancer: potential to improve diagnosis and prognosis.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774864

Neurotrophin stimulation of human melanoma cell invasion: selected enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774864

Expression of three extracellular matrix degradative enzymes in bladder cancer

31 October 2018

1 reference

12 December 2020

Heparanase Expression Correlates with Invasion and Poor Prognosis in Gastric Cancers

1 reference

12 December 2020

Human prostate carcinoma cells produce extracellular heparanase

1 reference

12 December 2020

A Molecular Signature in Superficial Bladder Carcinoma Predicts Clinical Outcome

1 reference

12 December 2020

Predicting outcome in minimally invasive (T1a and T1b) urothelial bladder cancer using a panel of biomarkers: a high-throughput tissue microarray analysis

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-9-385

1 reference

Dimensions Publication ID

27 July 2017

0 references

1 reference

27 July 2017

1 reference